Laurent Servais
Overview
Explore the profile of Laurent Servais including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
204
Citations
4815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dystrophin isoform deficiency and upper-limb and respiratory function in Duchenne muscular dystrophy
Chesshyre M, Ridout D, Stimpson G, Ricotti V, De Lucia S, Niks E, et al.
Dev Med Child Neurol
. 2025 Mar;
PMID: 40084496
Aim: To investigate the associations between mutations expected to differentially affect Dp140 expression and long-term trajectories of respiratory and upper-limb motor outcomes in Duchenne muscular dystrophy (DMD). Method: In a...
2.
Martin C, Servais L
Expert Opin Biol Ther
. 2025 Mar;
:1-16.
PMID: 40042390
Introduction: X-linked myotubular myopathy (XLMTM) is a life-threatening congenital disorder characterized by severe respiratory and motor impairment. This disease presents significant therapeutic challenges, with various strategies being explored to address...
3.
Servais L, Dangouloff T, Muntoni F, Scoto M, Baranello G
Lancet
. 2025 Feb;
405(10479):619-620.
PMID: 39986739
No abstract available.
4.
Vrscaj E, Dangouloff T, Osredkar D, Servais L
J Neuromuscul Dis
. 2025 Feb;
11(6):1180-1189.
PMID: 39973463
Background: Spinal muscular atrophy is a rare, genetic neuromuscular disorder. Disease-modifying therapies, when administered early, have shown improved outcomes, leading to the implementation of numerous newborn screening programs for spinal...
5.
Dangouloff T, Lang H, Benmhammed N, Servais L
J Neuromuscul Dis
. 2025 Feb;
:22143602241296286.
PMID: 39973413
Background: In recent years, treatments have been approved for certain neuromuscular diseases. In some cases, early pre-symptomatic treatment is necessary for optimal response, and thus newborn screening is critical. Objective:...
6.
Gonzalez Barral C, Servais L
J Neuromuscul Dis
. 2025 Feb;
:22143602241296280.
PMID: 39973412
Duchenne muscular dystrophy is a severe neuromuscular disorder characterized by progressive muscle degeneration resulting from mutations in the gene. Digital outcome measures offer a promising alternative to traditional outcome measures...
7.
Gonzalez Barral C, Servais L
Dev Med Child Neurol
. 2025 Jan;
PMID: 39888848
Wearable sensors have the potential to transform diagnosis, monitoring, and management of children who have neurological conditions. Traditional methods for assessing neurological disorders rely on clinical scales and subjective measures....
8.
Boemer F, Hovhannesyan K, Piazzon F, Minner F, Mni M, Jacquemin V, et al.
Nat Med
. 2025 Jan;
PMID: 39875687
The rapid development of therapies for severe and rare genetic conditions underlines the need to incorporate first-tier genetic testing into newborn screening (NBS) programs. A workflow was developed to screen...
9.
Moultrie F, Chiverton L, Hatami I, Lilien C, Servais L
Trends Mol Med
. 2025 Jan;
PMID: 39794178
Spinal muscular atrophy (SMA) is a devastating, degenerative, paediatric neuromuscular disease which until recently was untreatable. Discovery of the responsible gene 30 years ago heralded a new age of pioneering...
10.
Pereira C, Espadas G, Martins F, Bertrand A, Servais L, Sabido E, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769001
The nuclear envelope (NE), a protective membrane bordering the nucleus, is composed of highly specialized proteins that are indispensable for normal cellular activity. Lamina-associated polypeptide 1 (LAP1) is a NE...